Trial intelligence / Profile preview

Metaraminol dose-response for prevention of post-spinal hypotension during cesarean delivery

ChiCTR2000029490Phase 4Not yet recruiting

Sponsor
Jiaxing Maternity and Child Health Care Hospital
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of metahydroxylamine in hypotension (5 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoint: ED50 and ED95. Planned start Feb 2020; status: not yet recruiting.

02

Drugs

metahydroxylamine
03

Conditions

hypotension

Beyond the preview

Go deeper on ChiCTR2000029490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000029490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call